Global In Vitro Diagnostics Market to Reach US$ 178.1 Billion by 2032, Augmented by Increasing Prevalence of Infectious Diseases

April 24, 2023 | Healthcare

According to the latest report by IMARC Group, titled "In Vitro Diagnostics Market Report by Test Type (Clinical Chemistry, Molecular Diagnostics, Immunodiagnostics, Hematology, and Others), Product (Reagents and Kits, Instruments), Usability (Disposable IVD Devices, Reusable IVD Devices), Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, and Others), End User (Hospitals Laboratories, Clinical Laboratories, Point-of-care Testing Centers, Academic Institutes, Patients, and Others), and Region 2024-2032," the global In vitro diagnostics market size reached US$ 110.9 Billion in 2023. In vitro diagnostics (IVD) rely on medical tests that are performed on biological samples taken from a patient outside of their body in a laboratory or other medical settings. They are used to diagnose and predict diseases or conditions, such as infectious diseases, cancer, diabetes, and autoimmune disorders, to monitor the effectiveness of treatments and identify genetic mutations. They aid in minimizing hospital stays as they can generate instant results of samples for better diagnostic decisions. They enable multiple tests at the same time for screening for the presence of drugs in patients. 

Global In Vitro Diagnostics Market Trends:

The surging prevalence of chronic and infectious diseases and the growing aging population, which is more prone to develop these medical conditions, represent one of the major factors driving the demand for IVD around the world. Moreover, the increasing preference for personalized medicines and diagnostics is favoring the growth of the market. In addition, the rising demand for point of care testing (POCT) that allows healthcare providers to diagnose and monitor patients at the point of care quickly and easily is augmenting the growth of the market. Apart from this, the growing demand for IVD devices for immunodiagnostics or tissue diagnostics and hematology is influencing the market positively. Furthermore, key players are introducing automated IVD systems for laboratories and hospitals to provide efficient, accurate, and error-free diagnoses. This, coupled with the advent of IVD products with molecular diagnostic capabilities for delivering effective and precise results, is contributing to the market growth. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 178.1 Billion by 2032, exhibiting a CAGR of 5.24% during 2024-2032. 

Market Summary: 

  • On the basis of the test type, the market has been segmented into clinical chemistry, molecular diagnostics, immunodiagnostics, hematology, and others. Presently, molecular diagnostics hold the largest market share.
  • Based on the product, the market has been bifurcated into reagents and kits and instruments. Reagents and kits currently account for the biggest market share.
  • On the basis of the usability, the market has been categorized into disposable and reusable IVD devices.
  • Based on the application, the market has been segregated into infectious disease, diabetes, cancer/oncology, cardiology, autoimmune disease, nephrology, and others. Infectious disease exhibits a clear dominance in the market.
  • On the basis of the end user, the market has been classified into hospitals laboratories, clinical laboratories, point-of-care testing centers, academic institutes, patients, and others.
  • Region wise, the market has been divided into North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico and others); and the Middle East and Africa. Amongst these, North America (the United States and Canada) enjoys the leading position in the market.
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market. Some of the key players include Abbott Laboratories, Agilent Technologies Inc., Biomerieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, Fujifilm Holdings Corporation, Illumina Inc., Qiagen NV, Quest Diagnostics, Shimadzu Corporation, Siemens Healthcare GmbH, and Sysmex Corporation.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
 Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Test Type, Product, Usability, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Agilent Technologies Inc., Biomerieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, Fujifilm Holdings Corporation, Illumina Inc., Qiagen N.V, Quest Diagnostics, Shimadzu Corporation, Siemens Healthcare GmbH and Sysmex Corporation
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global In Vitro Diagnostics Market to Reach US$ 178.1 Billion by 2032, Augmented by Increasing Prevalence of Infectious Diseases
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More